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SS-68 is a derivative of indole, which demonstrated strong antiarrhythmic effects not associated with
signiﬁcant QT prolongation in dog models of atrial ﬁbrillation. Therefore, SS-68 was proposed as a new
antiarrhythmic drug and the present study is the ﬁrst describing its effects on action potentials (APs)
conﬁguration and elucidating the ionic mechanisms of these effects. Sharp microelectrodes were used to
record APs in isolated preparations of mouse atrial and ventricular myocardium. In both types of
myocardium 106 M SS-68 produced reduction of AP duration, 3  106 M failed to alter AP waveform
and 105 e 3  105 M prolonged APs. Sensitivity of main ionic currents to SS-68 was determined using
whole-cell patch clamp. Transient potassium current Ito was slightly inhibited by SS-68 with
IC50 ¼ 1.43  104 M. IKur was more sensitive with IC50 ¼ 1.84  105 M. Background inward rectiﬁer
showed very low sensitivity to SS-68 e only 104 M SS-68 caused signiﬁcant reduction of IK1. ICaL was
signiﬁcantly inhibited by 106M e 3  105 M SS-68. The IC50 value for the ICaL was 1.84  106 M. Thus,
main ionic currents of mouse cardiomyocytes are inhibited by SS-68 in the following order of potency:
ICaL > IKur > Ito > IK1. While lower concentration of SS-68 shorten APs via suppression of ICaL, higher
concentrations inhibit Kþ-currents leading to APs prolongation.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Atrial arrhythmias remain the great problem of clinical cardi-
ology. Besides the invasive methods of treatment, several antiar-
rhythmic drugs (AADs) are used for pharmacological cardioversion
of atrial ﬁbrillation (AF). While class I AADs, ﬂecainide and prop-
afenone demonstrate quite high effectiveness rates, the use of these
compounds carries also serious proarrhythmic risk side effects
including life-threatening ventricular arrhythmias, such as torsadeAnimal Physiology, Biological
kije Gory, 1, 12, 119991, Mos-
hkin).
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).de pointes (1). The class III AADs amiodarone, sotalol, ibutilide and
experimental vernakalant are much less risky, but also less effec-
tive, especially in the cases of persistent AF (2). Therefore, the
development of new AADs represents the actual aim for cardio-
vascular pharmacology.
The compound SS-68 has been selected after the screening of
105 new derivatives of indole, which were synthesized in the
Institute of Physical and Organic Chemistry of South Federal Uni-
versity. Besides moderate antianginal and coronary vasodilating
activity (3), SS-68 demonstrates marked antiarrhythmic effects
described in a number of preclinical studies. Although ventricular
arrhythmias obtained in barium (4), cesium (4) and other (5)
models were temperately sensitive to SS-68, the drug produced
strong antiarrhythmic effect (6) in supraventricular myocardium of
dogs with atrial ﬁbrillation induced by atrial tachypacing in situ
(6). In isolated preparations of guinea pig atrial myocardiumnese Pharmacological Society. This is an open access article under the CC BY-NC-ND
S.K. Bogus et al. / Journal of Pharmacological Sciences 128 (2015) 202e207 2034.1  107 M SS-68 prolonged effective refractory period by 15% of
control (6). Therefore, SS-68 was proposed as a new class III AAD for
treatment of atrial tachyarrhythmias. In dog models SS-68 did not
induce signiﬁcant QT prolongation in concentrations sufﬁcient for
effective termination of atrial ﬁbrillation, allowing to propose low
risk of proarrhythmic effects in ventricular myocardium.
Despite the putative high effectiveness and safety of SS-68, ﬁne
mechanisms of its antiarrhythmic action are poorly understood.
Basing on the strong antiarrhythmic effect in the canine atria
combined with negligible QT prolongation the drug was hypothe-
sized to suppress the ultrarapid delayed rectiﬁer (IKur), because in
the dog heart this current is present exclusively in supraventricular
myocardium (7). However, inhibition of IKur by SS-68 has never
been shown directly. The present study provides the ﬁrst descrip-
tion of SS-68 effects on the conﬁguration of action potentials (APs)
and major ionic currents in mammalian myocardium. Mouse heart
was used as amodel object, since the putative target of SS-68, IKur, is
strongly expressed in this tissue (8,9).
2. Materials and methods
2.1. Animals
Experiments conform to the Guide for the Care and Use of
Laboratory Animals published by the U.S. National Research Council
of the National Academies (8th edition, 2011) and the EU Directive
2010/63/EU for animal experiments. Experimental protocols were
approved by Bioethics Committee of Moscow State University.
Male outbred white mice (Mus musculus, n ¼ 35) weighing
23e30 gwere held in the animal house for 3e4weeks under a 12 h:
12 h light: dark photoperiod in standard T3 cages and fed ad libitum.
2.2. Transmembrane potential recordings of action potentials in
isolated murine myocardial preparations
Mice were anesthetized with intraperitoneal injection of
100 mg/kg ketamine and 10 mg/kg xylazine. Heparin (1000 U/kg)
was added to the anesthetics solution to prevent blood coagulation
in the coronary vessels of the excised heart. The chest was opened
and the heart was rapidly excised and immersed in a Tyrode so-
lution containing (in mM): NaCl 133.47, KCl 4.69, NaH2PO4$2H2O
1.35, NaHCO3 16.31, MgSO4$7H2O 1.18, CaCl2$2H2O 2.5 and glucose
7.7, bubbled with carbogen (95% O2, 5% CO2), with pH 7.4 ± 0.1. Two
types of isolated myocardial preparations were used: right auricle,
which did not contain the elements of sinoatrial node, and right
ventricular wall. During electrophysiological experiments prepa-
rations were paced with a constant frequency (7 Hz) via silver
teﬂon-coated electrodes. All preparations were pinned to the bot-
tom of an experimental chamber supplied with a physiological
solution at 10 ml min1 (38 C). After 1 h of equilibration, APs were
recorded from the endocardial surface of the preparationwith glass
microelectrodes (20e30 MU) ﬁlled with 3 M KCl. The signal was
digitized using ADC E14-140 (L-card, Moscow, Russia) with digita-
lization frequency of 20 KHz and analyzed using speciﬁc software
(L-card, Moscow, Russia; Synaptosoft, Fort Lee, NJ, USA). Stable
impalements were maintained during the entire period of SS-68
application. Changes in the resting membrane potential and AP
duration at 50% (APD50) and 90% of repolarization (APD90) were
estimated during data analysis.
2.3. Isolated myocyte preparation
The cell isolation procedure has been described before in
detail (10,11). Brieﬂy, the hearts were quickly excised and
attached to a Langendorff apparatus for retrograde perfusion withCa2þ-free solution containing (mmol L1): NaCl 118, KCl 4,
MgCl2$6H2O 1.1, NaH2PO4$2H2O 1.3, NaHCO3 25, Na-pyruvate 5,
glucose 11, taurine 20 and 1 g/l bovine serum albumin at pH of 7.2
adjusted with NaOH. After an initial perfusion period of 5 min
with the Ca2þ-free solution the hearts were perfused for
16e17 min with the same solution, supplemented with type II
collagenase (0.45 mg ml1) and 20 mM CaCl2. The perfusate was
continuously bubbled with carbogen (95% O2 þ 5% CO2) and the
temperature was equilibrated at 37 C. Finally, the ventricular
myocardium was separated, chopped and gently triturated to
release the cells into Kraftbrühe medium containing (mmol L1):
KCl 30, K glutamate 50, K2HPO4$2H2O 30, MgSO4$7H2O 3, EGTA
0.5, glucose 10, taurine 20 and Hepes 10 at pH of 7.3 adjusted
with KOH (12). The Kraftbrühe medium was used also for the
storage of murine cardiomyocytes.
2.4. Whole cell patch-clamp
The whole-cell voltage clamp recording of ionic currents was
performed using an EPC-800 USB (HEKA Instruments, Germany)
ampliﬁer. The myocytes were superfused in a small recording
chamber (RC-26; Warner Instrument Corp, Brunswick, CT, USA;
volume 150 ml) with an external saline solution containing (in
mmol L1): 150 NaCl, 5.4 KCl, 1.8 CaCl2, 1.2 MgCl2, 10 glucose, 10
Hepes, with pH adjusted to 7.6 at 20 C with NaOH. For registra-
tion of Ca2þ current KCl was substituted with equal quantity of
CsCl. The recordings were made at room temperature (24 ± 1 C).
Patch pipettes were pulled from borosilicate glass (Sutter Instru-
ment, CA, USA) using PC-10 puller (Narishige, Japan). For regis-
tration of Kþ currents the pipettes were ﬁlled with Kþ-based
electrode solution (composition in mmol L1: 140 KCl, 4 MgATP, 1
MgCl2, 5 EGTA, and 10 HEPES with pH adjusted to 7.2 with KOH).
Csþ-based electrode solution (composition in mmol L1: 130 CsCl,
5 MgATP, 15 tetraethylammonium chloride, 1 MgCl2, 5 oxaloace-
tate, 5 EGTA, and 10 HEPES with pH adjusted to 7.2 with CsOH)
was used for registration of Ca2þ current. Mean (±SEM) pipette
resistance was 3.4 ± 0.3 MU (n ¼ 132). Pipette capacitance, whole
cell capacitance and access resistance were routinely compen-
sated. The protocols used for registration of speciﬁc currents are
stated below.
The recorded traces were analyzed using WinWCP 4.6.9
(Strathclyde Electrophysiology Software, Glasgow, UK) and
Clampﬁt 9.2 (Molecular Devices, CA, USA) and the drug concen-
tration needed for half-maximal inhibition of the current, IC50, was
determined by ﬁtting a Hill equation (3 parameters) to the exper-
imental data (SigmaPlot 12.5, Systat Software, San Jose, CA, USA).
2.5. Drugs
4-aminopyridine and tetrodotoxin (TTX) were purchased from
Tocris (Bristol, UK). Nifedipine (a blocker of Ca2þ channels) and
barium chloride (a blocker of inward rectiﬁers) were purchased
from Sigma (St. Louis, MO, USA). Collagenase type II was purchased
from Worthington (Lakewood, NJ, USA). SS-68 was a gift from
Institute of Physical and Organic Chemistry of South Federal
University.
2.6. Statistics
All data in the text and ﬁgures except the original recordings
are presented as means ± S.E.M. for n experiments. Effects of SS-
68 on ionic currents and AP waveform were compared to the
basal current amplitude and control AP waveform, respectively, by
Wilcoxon test. P<0.05 was adopted as the level of statistical
signiﬁcance.
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3.1. Effects of SS-68 on AP waveform in ventricular and atrial
working myocardium
In preparations of murine ventricular myocardium resting
membrane potential was 80.7 ± 1.1 mV in control conditions
before application of SS-68. APD50 and APD90 were 13.1 ± 1.84 ms
and 37.3 ± 3.8 ms, respectively. Ascending concentrations of SS-68
were applied subsequently with 20 min of washout after each
concentration. While 3  107 M SS-68 failed to induce signiﬁcant
alterations of ventricular AP waveform,106 M SS-68 caused a clear
reduction of both APD50 and APD90 (Fig. 1A,B). Surprisingly, the
higher concentration, 3 106M, failed to induce signiﬁcant effects
(Fig. 1A,C) and 105 M produced marked prolongation of APs
(Fig. 1A,D). 3  105 M SS-68 caused the greater AP prolongation
(Fig.1A,E) combinedwith reduction of AP amplitude by 17.8 ± 3.7%
of control. This concentration was also the only one which signiﬁ-
cantly reduced resting potential e by 4 ± 1.12% of control. Thus,
lower concentrations (106 M) and higher concentrations (105 M,
3  105 M) of SS-68 produce the opposite effects on AP waveform
in ventricular tissue, while the medium one (3  106 M) has no
effect.
In the atrial preparations effects of SS-68 (106 M e 3  105 M)
were principally similar to those observed in the preparations of
right ventricular wall (Fig. 2), although 3  106 M produced sig-
niﬁcant increase in APD90. Therefore, in atrial myocardium 106 MFig. 1. Effects of SS-68 on action potentials (APs) in paced preparations of murine right
ventricular wall. A e changes in AP duration at 50% (APD50) and 90% (APD90) repo-
larization induced by SS-68 (106 e 3  105 M). An asterisk indicates a statistically
signiﬁcant effect (P < 0.05, Wilcoxon test, n ¼ 7). BeE e comparison of original AP
recordings in control conditions and during the application of SS-68. Each panel shows
the effect of one concentration of SS-68: Be106 M, Ce3  106 M, De105 M,
Ee3  105 M. All recordings are from one representative experiment, traces shown at
each panel were recorded from one cell.
Fig. 2. Effects of SS-68 on action potentials (APs) in paced preparations of murine right
atrium. A e changes in AP duration at 50% (APD50) and 90% (APD90) repolarization
induced by SS-68 (106 e 3  105 M). An asterisk indicates a statistically signiﬁcant
effect (P < 0.05, Wilcoxon test, n ¼ 8). BeE e comparison of original AP recordings in
control conditions and during the application of SS-68. Each panel shows the effect of
one concentration of SS-68: Be106 M, Ce3  106 M, De105 M, Ee3  105 M. All
recordings are from one representative experiment, traces shown at each panel were
recorded from one cell.SS-68 induced AP shortening on the contrary to all higher
concentrations.
To elucidate the mechanisms underlying the AP waveform al-
terations induced by SS-68 the effects of the drug on the main ionic
currents of murine heart were studied. Since ventricular myocytes
are easier to isolate and the set of ionic currents is almost the same
in atrial and ventricular cells, all patch-clamp experiments were
conducted on ventricular myocytes.3.2. Effects of SS-68 on delayed rectiﬁer potassium currents
In both ventricular and atrial myocytes from adult mice the AP
repolarization velocity is determined mainly by 3 potassium cur-
rents from delayed rectiﬁer family: transient outward current (Ito),
ultrarapid current (IKur) and so-called steady-state current Iss with
slow activation and very slow inactivation (8,13). Therefore, effects
of SS-68 on these currents in murine ventricular cells were studied
to ﬁnd out the mechanisms of accelerating or slowing of AP repo-
larization by SS-68.
Ito was recorded in the presence of 104 M 4-aminopyridine and
105 M TTX to block IKur (13) and fast sodium current (INa),
respectively. Since both nifedipine and verapamil and their de-
rivatives can reduce Ito (14), the current was recorded in the
absence of calcium current (ICa) blockers, however the calcium
concentration in the bath solution was reduced to 1 mM. In these
conditions ICa was quite negligible and Ito recordings were not
seriously contaminated.
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holding level of 80 mV to þ40 mV. However, another potassium
current, Iss, which is characterized by very slow inactivation (8),
could also be induced by such protocol. Therefore, only the fast
inactivating outward current was considered as Ito. The Ito ampli-
tude was estimated as the difference between the peak current and
the current in the end of depolarizing pulse.
After the Ito density reached the plateau level 6 concentrations
of SS-68 (106e3  104 M) were cumulatively applied into the
superfusion solution. The next higher concentration was added
once a steady level of Ito was achieved with the previous concen-
tration (approximately 1.5e2 min). Only the high concentrations of
SS-68 (105e 3 104 M) demonstrated signiﬁcant inhibition of Ito
(Fig. 3A,C). The IC50 value for the Ito determined in this experi-
mental series was 1.43  104 M. Special experiments using the
ascending depolarizing square-pulse protocol were conducted to
determine the shape of Ito currentevoltage (IeV) curve in normal
conditions and after application of 3  105 M, the minimal
effective concentration of SS-68. The drug inhibited the current, but
did not principally change the shape of IeV curve (Fig. 3B).
IKur was induced by 750 ms square depolarizing pulse
to þ40 mV, which was preceded by 300 ms prepulse to 40 mV
from the holding level of 80 mV (8). The prepulse was used to
inactivate both INa and Ito, therefore these experiments were con-
ducted without TTX in the bath solution. ICa was suppressed by
reduction of extracellular Ca2þ to 1 mM. After the density of IKur
reached the plateau level 6 concentrations of SS-68
(106e3  104 M) were cumulatively applied into the super-
fusion solution. Finally, 104 M 4-aminopyridine was applied toFig. 3. Effects of SS-68 on the transient outward potassium current (Ito) in murine
ventricular myocytes. A e original representative traces of current elicited by 750 ms
square-pulse depolarization to þ40 mV from the holding potential of 80 mV in
control conditions and during the application of 3  105 M SS-68. B e cur-
rentevoltage curves of peak Ito (ﬁlled circles e control conditions, empty circles e
3  105 M SS-68). The results are means ± S.E.M. of 8 myocytes from 4 mice. The peak
current amplitude was measured as the difference between the peak current and the
current in the end of depolarizing pulse. C e concentration dependence of SS-68 in-
hibition of the mouse peak Ito at þ40 mV. An asterisk indicates a statistically signiﬁcant
effect (P < 0.05, Wilcoxon test, n ¼ 8).assure a complete elimination of IKur and to obtain the residual
current (Fig. 4A).
That residual current consisted of the leakage current together
with Iss, which is not sensitive to 4-aminopyridine (13). In a special
series of experiments we applied SS-68 (104 M) in the presence of
104 M 4-aminopyridine. The registered Iss appeared to be
completely insensitive to the drug (data not shown). This fact
allowed us to estimate real IKur amplitude by subtraction of residual
current recorded after application of 104 M 4-aminopyridine in
the end of each experiment.
3  106 M and all higher concentrations of SS-68 signiﬁcantly
inhibited IKur (Fig. 4A,C). The IC50 value for the IKur determined in
this experimental series was 1.84  105 M. Similarly to the ex-
periments with Ito, SS-68 failed to change the shape of IeV curve
(Fig. 4B). Thus, IKur is more sensitive to SS-68 than Ito by almost one
order of magnitude.
3.3. Effects of SS-68 on background inward rectiﬁer potassium
current
The family of mammalian cardiac inward rectiﬁers consists of 3
distinct currents: (i) the background inward rectiﬁer current (IK1),
(ii) the acetylcholine-activated inward rectiﬁer (IKACh) and (iii) the
ATP-sensitive current (IKATP) (15). However, IKACh and IKATP are ab-
sent in normal conditions, when the muscarinic receptors are not
stimulated and intracellular ATP content is not too low. Therefore,
we have studied the effects of SS-68 exclusively on the background
current, IK1. During the recording of IK1105 M nifedipine and 3mMFig. 4. Effects of SS-68 on the ultrarapid delayed rectiﬁer potassium current (IKur) in
murine ventricular myocytes. A e original representative traces of current recorded in
control conditions, during the application of 105 M SS-68 and after ﬁnal addition of
104 M 4-aminopyridine. The current was elicited by 750 ms square-pulse depolari-
zation to þ40 mV applied after depolarizing pre-pulse to 40 mV from the holding
potential of 80 mV. B e currentevoltage curves of peak IKur (ﬁlled circles e control
conditions, empty circles e 105 M SS-68). The results are means ± S.E.M. of 8 myo-
cytes from 4 mice. The current amplitude was determined as the peak current after
subtraction of residual current recorded in the presence of 104 M 4-aminopyridine. C
e concentration dependence of SS-68 inhibition of the mouse IKur at þ40 mV. An
asterisk indicates a statistically signiﬁcant effect (P < 0.05, Wilcoxon test, n ¼ 8).
Fig. 6. Effects of SS-68 on the L-type calcium current (ICaL) in murine ventricular
myocytes. A e original current tracings of ICaL (after leak subtraction) from a repre-
sentative experiment recorded in control conditions and during the application of
106 M SS-68. The current was elicited by 250 ms square-pulse depolarization
to þ10 mV from the holding potential of 40 mV. B e concentration dependence of SS-
68 inhibition of the mouse ICaL measured at þ10 mV. The current amplitude was
determined as the difference between the peak ICaL and the current in the end of
depolarizing pulse. The results are means of 9 myocytes from 5 mice. An asterisk in-
dicates a statistically signiﬁcant difference (P < 0.05, Wilcoxon test) from the control
value.
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Ito þ IKur, respectively. The holding potential was set to 40 mV in
order to inactivate INa. IK1 was elicited by 1-s repolarizing voltage
ramps from þ60 mV to 120 mV (Fig. 5, inset).
IK1 showed very low sensitivity to SS-68 e only 104 M (Fig. 5)
and 3  104 M SS-68 caused signiﬁcant reduction of the maximal
inward component of current by 17.2 and 27.3%, respectively.
Therefore, AP prolongation by SS-68 is unlikely to be attributed to
suppression of IK1.
3.4. Effects of SS-68 on ICaL
ICaL was recorded using the Csþ-based pipette and bath solu-
tions. Together with addition of TEA to the pipette solution this
allowed to exclude Kþ currents. The holding level was set
to 40 mV to suppress both INa and ICaT. The current was elicited
by 250 ms depolarizing square pulses to þ10 mV. While
3  107 M SS-68 failed to change ICaL signiﬁcantly, all higher
concentrations (106 M e 3  105 M) caused marked inhibition
of ICaL (Fig. 6). The IC50 value for the ICaL was 1.84  106 M. Thus,
ICaL appeared to be more sensitive to SS-68 than all studied Kþ
currents.
4. Discussion
In the present study we describe effects of a new potential
antiarrhythmic drug SS-68 on AP waveform in working atrial and
ventricular myocardial preparations and possible ionic mecha-
nisms of these effects. Surprisingly, low concentration of SS-68
(106 M) shortens AP in both atrium and ventricle, while higher
concentrations (105 M, 3 105 M) increase APD. This controversy
may be explained by the different sensitivity of ionic currents to SS-
68. Two of ﬁve investigated currents demonstrate relatively high
sensitivity to the drug: ICaL and IKur. ICaL is the most sensitive
(IC50 ¼ 1.84  106 M), therefore it is likely that 106 M SS-68 is
enough to produce substantial inhibition of ICaL in multicellular
preparations, but not enough for suppression of IKur. Inhibition of
ICaL alone leads to decrease in APD (16). However, higher concen-
trations of SS-68 induce reduction of IKur together with suppression
of ICaL. The former effect masks the AP shortening at 3 106 M and
overwhelms it at higher concentrations resulting in AP
prolongation.Fig. 5. Currentevoltage curves of basal inward rectiﬁer potassium current (IK1) from a
representative experiment in control conditions and during the application of 104 M
SS-68. The current was elicited by voltage ramp protocol shown at the inset. Curves
were built from original traces after subtraction of the leakage current, which was
recorded in the presence of 2 mM BaCl2.In general, our results are in agreement with the previous
studies of SS-68 cardiotropic effects. In the present study we
describe suppression of IKur by SS-68 and this effect may underlie
the previously described antiarrhythmic action of SS-68 in dog
atria, because in dogs IKur is expressed exclusively in supraven-
tricular myocardium (17).
Prolongation of effective refractory period previously shown in
guinea pigs (6) conﬁrms with slowing of AP repolarization induced
by high concentrations of SS-68 in mouse myocardium. However,
concentrations of SS-68 which effective in mice are much higher
than nanomolar concentrations prolonging the effective refractory
period in guinea pig myocardium. Unlike murine cardiomyocytes
the cells from guinea pig heart express slow and fast delayed rec-
tiﬁers: IKs and IKr (18). Therefore, the described inter-species dif-
ference in sensitivity to SS-68 may be attributed to inhibition of IKs
and IKr by the studied drug leading to AP prolongation in guinea pig
heart.
It should be noted that the obtained data are surely not enough
to distinguish the clinical perspectives of the studied drug. The
pattern of ionic current expressed in mouse myocardium generally
differs from those in human heart. For example, Iss and corre-
sponding Kv2.1 channels (9) have not been described in human
cardiomyocytes to our knowledge. Moreover, in human atrial and
especially ventricular myocardium the prevalent repolarizing cur-
rent is IKr and, to a lesser extent, IKs. These currents are not func-
tionally relevant in myocardium from adult mouse (8). Therefore
effects of SS-68 in humansmay differ much from described in mice.
Further patch-clamp studies should check the possible effect of SS-
68 in guinea pig or rabbit myocytes, which have pattern of ionic
channels closer to human cardiac myocytes.
Further, dual concentration-dependent effects of SS-68 on APD
makes the probable clinical use of the drug more complicated. AP
S.K. Bogus et al. / Journal of Pharmacological Sciences 128 (2015) 202e207 207shortening produced by lower concentrations of SS-68 may act as a
proarrhythmic effect in atrial myocardium. However, inhibition of
ICaL, which underlies this effect, might be very beneﬁcial in ven-
tricular myocardium by reducing the probability of torsade de
pointes (TdP), which is frequent and dangerous side effect of class
III AADs.
Other potential targets of SS-68 preclinical investigations
include effects of the drug on late sodium current and outward
current of sodiumecalcium exchanger, which are both considered
as proarrhythmic factors in normal and pathological conditions
(19). Putative effects of SS-68 pulmonary veins also deserves special
study, since crucial role of their myocardial sleeves in genesis of
atrial arrhythmias gets more and more conﬁrmation in the recent
studies (20,21).
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